Healthcare provider profile · identity verified

Raymond James Browne, MD

Internal Medicine · BIRMINGHAM, AL · NPI 1194705178

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	438	151
Zolpidem Tartrate	Zolpidem Tartrate	394	71
Amlodipine Besylate	Amlodipine Besylate	359	131
Lisinopril	Lisinopril	259	85
Alprazolam	Alprazolam	221	49
Clonazepam	Clonazepam	196	32
Levothyroxine Sodium	Levothyroxine Sodium	195	71
Gabapentin	Gabapentin	194	73
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	175	37
Losartan Potassium	Losartan Potassium	172	74
Pantoprazole Sodium	Pantoprazole Sodium	172	68
Rosuvastatin Calcium	Rosuvastatin Calcium	146	58
Eliquis	Apixaban	140	37
Trazodone Hcl	Trazodone Hcl	135	65
Metformin Hcl	Metformin Hcl	129	53
Meloxicam	Meloxicam	120	43
Tramadol Hcl	Tramadol Hcl	119	32
Olmesartan Medoxomil	Olmesartan Medoxomil	104	44
Famotidine	Famotidine	103	45
Omeprazole	Omeprazole	103	43
Metoprolol Succinate	Metoprolol Succinate	102	40
Montelukast Sodium	Montelukast Sodium	98	35
Tamsulosin Hcl	Tamsulosin Hcl	96	34
Allopurinol	Allopurinol	89	35
Escitalopram Oxalate	Escitalopram Oxalate	87	34
Pravastatin Sodium	Pravastatin Sodium	86	36
Simvastatin	Simvastatin	85	28
Ezetimibe	Ezetimibe	81	25
Citalopram Hbr	Citalopram Hydrobromide	76	27
Fluticasone Propionate	Fluticasone Propionate	75	29
Ozempic	Semaglutide	69	16
Hydrochlorothiazide	Hydrochlorothiazide	68	25
Sertraline Hcl	Sertraline Hcl	67	29
Metoprolol Tartrate	Metoprolol Tartrate	66	27
Duloxetine Hcl	Duloxetine Hcl	65	26
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	62	17
Methocarbamol	Methocarbamol	61	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	23
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	53	16
Celecoxib	Celecoxib	52	20
Carvedilol	Carvedilol	51	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	48	29
Pregabalin	Pregabalin	47	18
Furosemide	Furosemide	45	21
Potassium Chloride	Potassium Chloride	45	18
Esomeprazole Magnesium	Esomeprazole Magnesium	44	20
Buspirone Hcl	Buspirone Hcl	43	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	43	15
Diclofenac Sodium	Diclofenac Sodium	42	11
Chlorthalidone	Chlorthalidone	41	21
Irbesartan	Irbesartan	41	11
Mirtazapine	Mirtazapine	40	15
Lorazepam	Lorazepam	39	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	22
Labetalol Hcl	Labetalol Hcl	37	14
Albuterol Sulfate Hfa	Albuterol Sulfate	35	17
Mounjaro	Tirzepatide	35	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	12
Atenolol	Atenolol	33	11
Doxazosin Mesylate	Doxazosin Mesylate	33	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	12
Wixela Inhub	Fluticasone Propion/Salmeterol	32	15
Trulicity	Dulaglutide	31	suppressed
Raloxifene Hcl	Raloxifene Hcl	30	12
Temazepam	Temazepam	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Testosterone Cypionate	Testosterone Cypionate	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	12
Topiramate	Topiramate	26	suppressed
Telmisartan	Telmisartan	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Tresiba Flextouch U-200	Insulin Degludec	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Azelastine Hcl	Azelastine Hcl	23	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	23	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Fentanyl	Fentanyl	22	suppressed
Finasteride	Finasteride	22	suppressed
Promethazine Hcl	Promethazine Hcl	22	suppressed
Verapamil Er	Verapamil Hcl	22	suppressed
Modafinil	Modafinil	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Amoxicillin	Amoxicillin	20	17
Azithromycin	Azithromycin	20	19
Jardiance	Empagliflozin	20	11
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Cephalexin	Cephalexin	19	12
Fluconazole	Fluconazole	18	12
Januvia	Sitagliptin Phosphate	18	suppressed
Glimepiride	Glimepiride	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Estradiol	Estradiol	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Ondansetron Odt	Ondansetron	16	12
Valacyclovir	Valacyclovir Hcl	16	12
Xarelto	Rivaroxaban	16	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	15	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Scopolamine	Scopolamine	14	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Linzess	Linaclotide	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Baclofen	Baclofen	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Misoprostol	Misoprostol	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Armodafinil	Armodafinil	11	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error